Cancer Conversations Podcast – Episode #15: What You Need to Know About Lung Cancer Treatment and Research

May 17, 2017

Oxnard and Paweletz liquid biopsy
Geoffrey Oxnard, MD (left), with Cloud Paweletz, PhD

Lung cancer is the second most common cancer in men and women, but lung cancer research is advancing rapidly and treatments are improving at an astonishing pace. “Lung cancer research has changed so much today that it’s even hard to estimate what we’re going to be doing in the future,” says Geoffrey Oxnard, MD, of Dana-Farber’s Lowe Center for Thoracic Oncology.

In this Cancer Conversations podcast episode, Oxnard discusses these new developments, including targeted therapies and individualized treatment plans.  “Clinical trials today are much more nuanced about finding the right drug for the right patient,” he adds.

Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play, the Stitcher appTuneIn app, and RSS.

The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes and the Dana-Farber podcast page for more cancer podcast series.